Menu
GWAS Study

Genome-wide meta-analyses of nonsyndromic orofacial clefts identify novel associations between FOXE1 and all orofacial clefts, and TP63 and cleft lip with or without cleft palate.

Leslie EJ, Carlson JC, Shaffer JR et al.

28054174 PubMed ID
GWAS Study Type
12852 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

LE
Leslie EJ
CJ
Carlson JC
SJ
Shaffer JR
BA
Butali A
BC
Buxó CJ
CE
Castilla EE
CK
Christensen K
DF
Deleyiannis FW
LF
Leigh Field L
HJ
Hecht JT
ML
Moreno L
OI
Orioli IM
PC
Padilla C
VA
Vieira AR
WG
Wehby GL
FE
Feingold E
WS
Weinberg SM
MJ
Murray JC
BT
Beaty TH
MM
Marazita ML
Chapter II

Abstract

Summary of the research findings

Nonsyndromic orofacial clefts (OFCs) are a heterogeneous group of common craniofacial birth defects with complex etiologies that include genetic and environmental risk factors. OFCs are commonly categorized as cleft lip with or without cleft palate (CL/P) and cleft palate alone (CP), which have historically been analyzed as distinct entities. Genes for both CL/P and CP have been identified via multiple genome-wide linkage and association studies (GWAS); however, altogether, known variants account for a minority of the estimated heritability in risk to these craniofacial birth defects. We performed genome-wide meta-analyses of CL/P, CP, and all OFCs across two large, multiethnic studies. We then performed population-specific meta-analyses in sub-samples of Asian and European ancestry. In addition to observing associations with known variants, we identified a novel genome-wide significant association between SNPs located in an intronic TP63 enhancer and CL/P (p = 1.16 × 10-8). Several novel loci with compelling candidate genes approached genome-wide significance on 4q21.1 (SHROOM3), 12q13.13 (KRT18), and 8p21 (NRG1). In the analysis of all OFCs combined, SNPs near FOXE1 reached genome-wide significance (p = 1.33 × 10-9). Our results support the highly heterogeneous nature of OFCs and illustrate the utility of meta-analysis for discovering new genetic risk factors.

1,445 Asian ancestry case-parent trios, 161 Asian ancestry controls, 208 European ancestry cases,1,284 European ancestry case-parent trios, 835 European ancestry controls, 610 Latino or African cases, 663 Latino or African case-parent trios, 704 Latino or African controls, 35 case-parent trios.

Chapter III

Study Statistics

Key metrics and study information

12852
Total Participants
GWAS
Study Type
No
Replicated
African unspecified, Hispanic or Latin American, Asian unspecified, European
Ancestry
Colombia, Argentina, Puerto Rico, U.S., Niger, Guatemala, Nigeria, Ethiopia, Singapore, China, Philippines, Taiwan, Republic of Korea, Turkey, Norway, Denmark, Spain
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.